RxDoctor Payments DataLook up a doctor →

Andrea Russo, MD

Cardiovascular Disease · Camden, NJNPI 1396777694

Payments from drug & device makers

$415,062in general payments, 2019–2025

Across 520 payments — averaging $798.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$165K
  • Boston Scientific$97K
  • Novartis$47K
  • Sanofi-aventis U.S. LLC$41K
  • Biosense Webster, Inc.$16K
  • Biotronik Inc.$12K
  • plus $37K from 13 others
$10,250in research payments, 2019–2025

Across 14 payments — averaging $732.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$8K
  • Sanofi-aventis U.S. LLC$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$415,062 in reported general payments places this provider in the 95th percentile of 1,006 cardiovascular disease providers in New Jersey.

See all cardiovascular disease providers in New Jersey

Medicare billing

Part B allowed, 2024
$176,254
Medicare patients
338
Services billed
2,675

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Camden

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →